1.      Abdallah EAA, Said RN, Mosallam DS, Moawad EMI, Kamal NM, Fathallah MGE. Serial serum alkaline phosphatase as an early biomarker for osteopenia of prematurity. Medicine (Baltimore). 2016;95(37): e4837. doi:10.1097/MD.0000000000004837. PMID: 27631238; PMCID: PMC5402581.

2.      Alsaif S, Alsherbini L, Aljarbou T, Alshareef M, Ali K. Fractures associated with metabolic bone disease in extremely preterm and extremely low birth weight infants before and after a bone health program. Children (Basel). 2025;12(11):1574. doi:10.3390/children12111574. PMID: 41300690; PMCID: PMC12651200.

3.      Backström MC, Kuusela AL, Mäki R. Metabolic bone disease of prematurity. Ann Med. 1996;28(4):275-282. doi:10.3109/07853899608999080. PMID: 8862679.

4.      Bhatia J. Fluid and electrolyte management in the very low birth weight neonate. J Perinatol. 2006;26(Suppl 1):S19-S21. doi:10.1038/sj.jp.7211466. PMID: 16625217.

5.      Charoenngam N, Ayoub D, Holick MF. Nutritional rickets and vitamin D deficiency: consequences and strategies for treatment and prevention. Expert Rev Endocrinol Metab. 2022;17(4):351-364. doi:10.1080/17446651.2022.2099374.

6.      Chinoy A, Mughal MZ, Padidela R. Current status in therapeutic interventions of neonatal bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020;25(1):101075. doi:10.1016/j.siny.2019.101075.

7.      Faienza MF, D'Amato E, Natale MP, Grano M, Chiarito M, Brunetti G, D'Amato G. Metabolic bone disease of prematurity: diagnosis and management. Front Pediatr. 2019;7:143. doi:10.3389/fped.2019.00143. PMID: 31032241; PMCID: PMC6474071.

8.      Fanaroff AA, Martin RJ, Walsh MC, editors. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 12th ed. Philadelphia: Elsevier; 2024. p.109-115.

9.      Juul SE, Gleason CA, editors. Avery’s Diseases of the Newborn. 10th ed. Philadelphia: Elsevier; 2017.

10.  Korkmaz HA, Ozkan B. Hypoparathyroidism in children and adolescents. Ann Pediatr Endocrinol Metab. 2023;28(3):159-167. doi:10.6065/apem.2346096.048.

11.  Mahmoud MA, Hamed AM, Hassan K. Hypocalcemia and hypomagnesemia in neonates with convulsions in a tertiary level NICU: a prospective cross-sectional study. Ann Neonatol. 2025;7(1):73-92. doi:10.21608/anj.2024.316607.1102.

12.  Markopoulou P, Doulgeraki A, Koutroumpa A, Polyzois G, Athanasopoulou H, Kanaka-Gantenbein C, Siahanidou T. The long-term impact of preterm birth on metabolic bone profile and bone mineral density in childhood. Metabolites. 2025;15(7):463. doi:10.3390/metabo15070463.

13.  Mimouni FB, Mandel D, Lubetzky R, Senterre T. Calcium, phosphorus, magnesium and vitamin D requirements of the preterm infant. World Rev Nutr Diet. 2014;110:140-151. doi:10.1159/000358463.

14.  Montaner Ramón A. Risk factors of bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020;25(1):101079. doi:10.1016/j.siny.2019.101079.

15.  Moss CR. Fluid and electrolyte management in the neonate: sodium and chloride. Neonatal Netw. 2022;41(3):137-144. doi:10.1891/11-T-759.

16.  Ryan BA, Kovacs CS. Calciotropic and phosphotropic hormones in fetal and neonatal bone development. Semin Fetal Neonatal Med. 2020;25(1):101062. doi:10.1016/j.siny.2019.101062.

17.  Sethi A, Bhatia J. Disorders of calcium, phosphorous, and magnesium in the newborn. In: Bhatia J, Parish A, editors. Care of the Newborn. Cham: Springer; 2018. p.109-115. doi:10.1007/978-3-319-90771-8_9.

18.  Thomas N. Nutritional care of preterm infants: scientific basis and practical guidelines. Indian J Med Res. 2016;143(4):531-532. doi:10.4103/0971-5916.184296.

19.  Tominaga T, Ikeda K, Awazu M. Transient hypercalcemia followed by hypocalcemia in a preterm infant after maternal magnesium sulfate therapy. Clin Pediatr Endocrinol. 2022;31(2):77-80. doi:10.1297/cpe.2021-0061.

20.  Türk Neonatoloji Derneği. Sıvı-Elektrolit Dengesi Rehberi. Ankara: TND; 2021.